Scarica l'app Stockscreener
84.20
5.14%
-4.54
Dopo l'orario di chiusura:
84.26
0.06
+0.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$88.74
Aprire:
$88.7
Volume 24 ore:
2.47M
Relative Volume:
1.10
Capitalizzazione di mercato:
$13.91B
Reddito:
$4.39B
Utile/perdita netta:
$-1.58B
Rapporto P/E:
-8.4538
EPS:
-9.96
Flusso di cassa netto:
$546.00M
1 W Prestazione:
-10.41%
1M Prestazione:
-35.79%
6M Prestazione:
-35.38%
1 anno Prestazione:
-40.09%
Intervallo 1D:
$83.79
$88.81
Intervallo di 1 settimana:
$83.79
$96.88
Portata 52W:
$83.79
$156.66
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
84.20 | 13.91B | 4.39B | -1.58B | 546.00M | -9.96 |
|
TMO
Thermo Fisher Scientific Inc
|
523.49 | 198.19B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.71 | 148.92B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
126.33 | 36.52B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
437.15 | 35.63B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
184.91 | 33.12B | 15.41B | 1.37B | 2.11B | 7.50 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today - Benzinga
Illumina stock touches 52-week low at $87.29 amid market shifts - Investing.com
INVESTOR ALERT: Levi & Korsinsky Notifies Illumina, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineILMN - ACCESS Newswire
Biochips Market Generated Opportunities, Future Scope 2025-2032 | PerkinElmer, Inc., Fluidigm Corporation, Illumina - openPR
Bank of New York Mellon Corp Has $454.62 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Stock Holdings Decreased by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
ARK Investment Management LLC Takes Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Y Intercept Hong Kong Ltd Boosts Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
National Pension Service Decreases Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Los Angeles Capital Management LLC Sells 41,352 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Sabal Trust CO Buys Shares of 7,266 Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Impax Asset Management Group plc Sells 6,320 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
FourThought Financial Partners LLC Takes Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Weil Company Inc. - MarketBeat
Tariffs, Cut Funding Spur Illumina’s Worst Month in 23 Years - Yahoo Finance
Illumina's Challenging February: Tariffs, Competition, and Funding CutsNews and Statistics - IndexBox, Inc.
Illumina to lay off 96 San Diego employees - MedTech Dive
AI Models Writing DNA and Designing Enzymes, Some Pre-AGBT News - Genetic Engineering & Biotechnology News
Investor Network: Illumina, Inc. to Host Earnings Call - ACCESS Newswire
HSBC downgrades Illumina on China risks, funding concerns - Investing.com
China Tariffs, Cut Funds Spur Illumina’s Worst Month in 23 Years - Bloomberg
What Makes Illumina (ILMN) an Attractive Opportunity? - Insider Monkey
Here's Why Illumina (ILMN) is a Strong Value Stock - Yahoo Finance
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineILMN - ACCESS Newswire
SHAREHOLDER ALERT: Potential Recovery for Illumina, Inc. (ILMN) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Illumina, Inc. to Host Earnings Call - ACCESS Newswire
Illumina, Inc. (NASDAQ:ILMN) Shares Bought by Hardman Johnston Global Advisors LLC - MarketBeat
INVESTOR ALERT: Potential Recovery for Illumina, Inc. (ILMN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Strength in numbers: How the Rare Barometer supports the rare disease community - Illumina
Synthetic Biology Market Projected To Witness Substantial Growth, 2025-2032: GenScript, Amyris, Illumina, - EIN News
Metagenomics Market: Gaining Unprecedented Momentum | Illumina, PerkinElmer - openPR
The Jackson Laboratory advances precision medicine with an end-to-end workflow - Illumina
Roche SBX announcement creates more uncertainty for Illumina, says RBC - MSN
The Jackson Laboratory advances precision medicine with an end-to-end NGS workflow - Illumina
Key Digital Genome Market Trend 2025-2034: Innovative Products In The Digital Genome Market Illumina's Nova... - WhaTech
Truist Financial Corp Sells 2,989 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Global Long Read Sequencing Market Detailed In New Research Report 2025 | Illumina Inc., Pacific Biosciences, - openPR
Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™. - GlobeNewswire Inc.
$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today - Benzinga
What Makes Illumina (ILMN) a Long Term Bet? - MSN
Illumina’s high-throughput single-cell CRISPR prep makes gene editing a reality - Illumina
Ieq Capital LLC Boosts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Objective long/short (ILMN) Report - news.stocktradersdaily.com
Illumina reveals expansive multiomics technology roadma By Investing.com - Investing.com Nigeria
Illumina (ILMN): Building The Picks And Shovels Of the Genomic Age - Securities.io
ILMN Stock Might Rise From Collaboration With Broad Clinical Labs - Yahoo Finance
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology - PR Newswire
Illumina reveals expansive multiomics technology roadma - Investing.com
Illumina Innovation Roadmap - Illumina
Can Illumina's New Million-Cell Analysis Technology Revolutionize CRISPR Research? - StockTitan
Biochips Market Growth | Trends, Size & Forecast 2024-2031 | Abbott Laboratories, PerkinElmer Inc., Illumina, Inc. - openPR
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.02%
2.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):